XOMA CORPORATION (FKA XOMA (US) LLC) for XOMA CORPORATION (FKA XOMA (US) LLC)
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues relating to the draft Tax Reform Act of 2014, all provisions pertaining to an orphan drug tax credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA | — |
Health Issues HCR
Issues relating to the implementation of PL 111-148 "Patient Protection and Affordable Care Act of 2010," all provisions pertaining to patient access to treatments. HR 460 "Patients' Access to Treatment Act of 2013," all provisions pertaining to coverage and reimbursement issues for specialty tier drugs. Draft legislation to be called "21st Century Cures Act," all provisions pertaining to patient access to treatments and orphan drug incentives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.